462 related articles for article (PubMed ID: 17559806)
1. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
Liang Z; Brooks J; Willard M; Liang K; Yoon Y; Kang S; Shim H
Biochem Biophys Res Commun; 2007 Aug; 359(3):716-22. PubMed ID: 17559806
[TBL] [Abstract][Full Text] [Related]
2. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.
Song ZY; Wang F; Cui SX; Qu XJ
Cancer Invest; 2018 Jan; 36(1):10-18. PubMed ID: 29381400
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
5. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang XP; DeCarvalho AC; Katakowski M; Bobbitt K; Mikkelsen T; Chopp M
Cancer Lett; 2006 May; 236(1):39-45. PubMed ID: 15967572
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
7. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor.
Yang SX; Chen JH; Jiang XF; Wang QL; Chen ZQ; Zhao W; Feng YH; Xin R; Shi JQ; Bian XW
Biochem Biophys Res Commun; 2005 Sep; 335(2):523-8. PubMed ID: 16084492
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
[TBL] [Abstract][Full Text] [Related]
9. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia.
Wei L; Zhang B; Cao W; Xing H; Yu X; Zhu D
J Recept Signal Transduct Res; 2015; 35(4):329-39. PubMed ID: 25421526
[TBL] [Abstract][Full Text] [Related]
11. Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.
Prasad A; Qamri Z; Wu J; Ganju RK
J Leukoc Biol; 2007 Sep; 82(3):465-76. PubMed ID: 17565045
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Murakami K; Miyake Y; Matsuo T
Clin Exp Immunol; 2005 Sep; 141(3):467-74. PubMed ID: 16045736
[TBL] [Abstract][Full Text] [Related]
13. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis.
Wang J; Wang J; Sun Y; Song W; Nor JE; Wang CY; Taichman RS
Cell Signal; 2005 Dec; 17(12):1578-92. PubMed ID: 16005185
[TBL] [Abstract][Full Text] [Related]
14. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
[TBL] [Abstract][Full Text] [Related]
15. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
16. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
17. Study of angiogenic signaling pathways in hemangioblastoma.
Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
[TBL] [Abstract][Full Text] [Related]
18. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
[TBL] [Abstract][Full Text] [Related]
19. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
[TBL] [Abstract][Full Text] [Related]
20. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]